Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?

Autor Latif, Hira, Liu, Stephen V.
Vydáno v Ann Transl Med (2019)

Novel ALK mutation with durable response to brigatinib—a case report

Autor Latif, Hira, Liu, Stephen V.
Vydáno v Transl Lung Cancer Res (2020)

Chemo-immunotherapy as first-line treatment for small-cell lung cancer

Autor Farid, Saira, Liu, Stephen V.
Vydáno v Ther Adv Med Oncol (2020)

Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential

Autor Armstrong, Samantha A., Liu, Stephen V.
Vydáno v Adv Ther (2019)

Tracking the tail

Autor Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo
Vydáno v J Immunother Cancer (2020)

Drugs in development for small cell lung cancer

Autor Serzan, Michael T., Farid, Saira, Liu, Stephen V.
Vydáno v J Thorac Dis (2020)

LHRH and LHR genotypes and prostate cancer incidence and survival

Autor Ingles, Sue Ann, Liu, Stephen V, Pinski, Jacek
Vydáno 2013

Breast metastasis from nasopharyngeal carcinoma: A case report and review of the literature

Autor LEACH, BEN I., SUN, BONNIE, PETROVIC, LYDIA, LIU, STEPHEN V.
Vydáno 2013

Oral Chemotherapy for Treatment of Lung Cancer

Autor Jonna, Sushma, Reuss, Joshua E., Kim, Chul, Liu, Stephen V.
Vydáno v Front Oncol (2020)

Evidence to Date: Evaluating Pembrolizumab in the Treatment of Extensive-Stage Small-Cell Lung Cancer

Autor Riano, Ivy, Patel, Shruti R., Liu, Stephen V., Duma, Narjust
Vydáno v Clin Pract (2021)

Epigenetic Therapy in Lung Cancer

Autor Liu, Stephen V., Fabbri, Muller, Gitlitz, Barbara J., Laird-Offringa, Ite A.
Vydáno 2013

Product review on the Anti-PD-L1 antibody atezolizumab

Autor Shah, Neil J., Kelly, William J., Liu, Stephen V., Choquette, Karin, Spira, Alexander
Vydáno v Hum Vaccin Immunother (2017)

A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer

Autor Subramaniam, Deepa S., Liu, Stephen V., Crawford, Jeanette, Kramer, Jenna, Thompson, Jillian, Wang, Hongkun, Giaccone, Giuseppe
Vydáno v Front Oncol (2018)

Phase I study of the (177)Lu-DOTA(0)-Tyr(3)-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

Autor Kim, Chul, Liu, Stephen V, Subramaniam, Deepa S, Torres, Tisdrey, Loda, Massimo, Esposito, Giuseppe, Giaccone, Giuseppe
Vydáno v J Immunother Cancer (2020)

Response to Entrectinib in Differentiated Thyroid Cancer With a ROS1 Fusion

Autor Liu, Stephen V., Macke, Laura A., Colton, Bradley S., Imran, Sikandar S., Christiansen, Jason, Chow-Maneval, Edna, Hornby, Zachary, Multani, Pratik S.
Vydáno v JCO Precis Oncol (2017)

Effect of prior therapy on tumor mutational burden in NSCLC

Autor Jonna, Sushma, Vanderwalde, Ari, Nieva, Jorge, Poorman, Kelsey Anne, Saul, Michelle, von Buttlar, Xinyu, Hu, John Y., Liu, Stephen V.
Vydáno v Transl Lung Cancer Res (2021)

Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer

Autor Kim, In-Kyu, McCutcheon, Justine N., Rao, Guanhua, Liu, Stephen V., Pommier, Yves, Skrzypski, Marcin, Zhang, Yu-Wen, Giaccone, Giuseppe
Vydáno v Oncogene (2018)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma

Autor Cortinovis, Diego, Bidoli, Paolo, Canova, Stefania, Colonese, Francesca, Gemelli, Maria, Lavitrano, Maria Luisa, Banna, Giuseppe Luigi, Liu, Stephen V., Morabito, Alessandro
Vydáno v Cancers (Basel) (2021)

Rac1 promotes intestinal epithelial restitution by increasing Ca(2+) influx through interaction with phospholipase C-γ1 after wounding

Autor Rao, Jaladanki N., Liu, Stephen V., Zou, Tongtong, Liu, Lan, Xiao, Lan, Zhang, Xian, Bellavance, Emily, Yuan, Jason X.-J., Wang, Jian-Ying
Vydáno 2008

Racial Disparities in the Molecular Landscape of Cancer

Autor HEATH, ELISABETH I., LYNCE, FILIPA, XIU, JOANNE, ELLERBROCK, ANGELA, REDDY, SANDEEP K., OBEID, ELIAS, LIU, STEPHEN V., BOLLIG-FISCHER, ALICCIA, SEPAROVIC, DUSKA, VANDERWALDE, ARI
Vydáno v Anticancer Res (2018)